Full video transcriptClick to expand
Auto-generated transcript of @shad_asiama's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00Now for people that aren't getting prescribed TRT,
- 0:02but want the increase in testosterone,
- 0:04Nigerian shrub called fedogia agrestis.
- 0:08What does the other one give you?
- 0:09fedogia is usually taken at about 600 milligrams,
- 0:13and that can mean, the most dramatic effect I've ever seen
- 0:17was somebody who had testosterone down in the low twos,
- 0:20or I think it was like low twos,
- 0:22and he got it up to the 700 range, which,
- 0:24but that's an outlier, right?
- 0:26Most people are gonna see about a three to 400 point increase.
- 0:29And that's what the two of them synergistically want.
- 0:31fedogia will actually make the testes grow.
- 0:33It's a noticeable difference, so everybody wants that.
- 0:36This right here is fedogia agrestis,
- 0:38exactly what that doctor was talking about, man.
- 0:40If you're not taking fedogia,
- 0:41you are missing out on testosterone gains,
- 0:43because if you have a low testosterone,
- 0:45it's gonna be very, very difficult
- 0:47for you to grow muscles naturally.
- 0:48What am I talking about?
- 0:49Because I went from this to this naturally,
- 0:51so mark my words, I know exactly what I'm talking about, man.
- 0:53fedogia agrestis is gonna increase that energy and drop,
- 0:56it's gonna increase that testosterone level,
- 0:57and also help y'all recover faster than the GEMM.
- 0:59So if you see the link right there,
- 1:00and it's still not so now, yeah,
- 1:01it's your time to go get it before it's too late,
- 1:03but you will literally run back to this video
- 1:04a month or two from now, and thank me later.
- 1:06But do not forget that I'll put you on,
- 1:08and nobody else dead.
- 1:09God bless you guys, and I'm out.
- 1:11Peace.
Fadogia agrestis as 'natty TRT': what the evidence actually says
Quick answer
The creator positions fadogia agrestis as a practical alternative to prescribed testosterone replacement therapy for men with low testosterone, citing anecdotal increases of 300-700 ng/dL. No human clinical trial data supports testosterone-boosting efficacy at any dose in humans, and animal studies have raised safety flags around testicular toxicity at higher exposures. Men presenting with symptomatic low testosterone should pursue serum testosterone and LH testing through a licensed clinician before considering any supplement intervention.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Fadogia agrestis as 'natty TRT': what the evidence actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Fadogia agrestis as 'natty TRT': what the evidence actually says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Fadogia agrestis as 'natty TRT': what the evidence actually says" from Shad Asiama. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator positions fadogia agrestis as a practical alternative to prescribed testosterone replacement therapy for men with low testosterone, citing anecdotal increases of 300-700 ng/dL.
The reason this review is not generic is the source wording and the canonical claim label "trt this doctor exposed the natty trt supplement fadogiaagrestis." In this clip, the useful excerpt is: "Now for people that aren't getting prescribed TRT, but want the increase in testosterone, Nigerian shrub called fedogia agrestis." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator positions fadogia agrestis as a practical alternative to prescribed testosterone replacement therapy for men with low testosterone, citing anecdotal increases of 300-700 ng/dL.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator positions fadogia agrestis as a practical alternative to prescribed testosterone replacement therapy for men with low testosterone, citing anecdotal increases of 300-700 ng/dL. No human clinical trial data supports testosterone-boosting efficacy at any dose in humans, and animal studies have raised safety flags around testicular toxicity at higher exposures. Men presenting with symptomatic low testosterone should pursue serum testosterone and LH testing through a licensed clinician before considering any supplement intervention.
- Zero published human RCTs have tested whether fadogia agrestis raises testosterone in men at any dose.
- The primary cited study (Yakubu et al., 2005) used rats, not humans, and rat testosterone physiology does not reliably predict human outcomes.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Zero published human RCTs have tested whether fadogia agrestis raises testosterone in men at any dose.
- The primary cited study (Yakubu et al., 2005) used rats, not humans, and rat testosterone physiology does not reliably predict human outcomes.
- A follow-up animal study (Yakubu et al., 2008, Journal of Ethnopharmacology) identified potential testicular toxicity signals at higher doses, contradicting the safety framing in the video.
- A 300-700 ng/dL testosterone increase from an oral supplement would be clinically extraordinary and has no supporting human evidence.
- Low testosterone is a diagnosable condition. Serum testosterone and LH testing through a licensed provider is the appropriate first step, not a supplement purchase.
- The FDA does not evaluate supplements for efficacy before they reach market, meaning product claims are not independently verified.
- Supplement purity and alkaloid content in fadogia agrestis products vary significantly, making any confident dosing claim from an influencer essentially meaningless without third-party testing data.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @shad_asiama actually say?
The creator claims that fadogia agrestis, a "Nigerian shrub," can raise testosterone by "three to 400 points" in most people, with one dramatic case going from the low 200s to the 700 range. He also says it makes "the testes grow" noticeably, boosts energy, accelerates recovery, and positions it as a legitimate alternative for people who can't get prescribed TRT. He ends with a product link and a "thank me later" guarantee.
To be clear: he's describing a supplement as capable of delivering outcomes that rival or approach clinical testosterone therapy. That's a significant claim, and it deserves scrutiny proportional to how confidently he made it.
Does the science back this up?
No, not remotely at the scale he's describing. The human evidence for fadogia agrestis is essentially nonexistent. Every meaningful study comes from rodents, and extrapolating rat data to human testosterone physiology is one of the oldest mistakes in supplement marketing.
The most-cited animal study (Yakubu et al., 2005, Asian Journal of Andrology) found that fadogia agrestis extract increased testosterone in male rats, along with testicular changes. Sounds promising until you realize rats are not small humans, and luteinizing hormone signaling, Leydig cell density, and hepatic metabolism differ enough that rodent testosterone responses routinely fail to replicate in humans. A follow-up by the same group (Yakubu et al., 2008, Journal of Ethnopharmacology) actually flagged potential testicular toxicity at higher doses in rats, which is the opposite of the "testes grow" selling point the creator uses. There are no published randomized controlled trials in humans demonstrating fadogia agrestis raises testosterone by any measurable amount, let alone 300 to 700 points. The "outlier" case he describes, someone going from the low 200s to 700 ng/dL, has no citation, no context, and no verification. A change that large in a clinically hypogonadal man would typically require actual TRT.
What did they get wrong (or right)?
Wrong on the numbers. A 300-700 ng/dL increase from an oral supplement with zero human trial data is not a reasonable claim. It's a sales pitch dressed as anecdote. The creator offers no bloodwork, no timeframe, no controlling for confounders like sleep, diet, or training changes. "Most people are gonna see about a three to 400 point increase" is stated as if it's an established clinical finding. It isn't.
Wrong on mechanism framing. Saying it makes "the testes grow" as a positive feature glosses over the fact that testicular enlargement from a pharmacologically active compound is not inherently safe or desirable, especially given the Yakubu 2008 toxicity signals.
Partially right on one thing: low testosterone does make muscle building harder. That part is well-supported (Bhasin et al., 2001, New England Journal of Medicine). But acknowledging a real problem doesn't validate an unproven solution.
- Claim that 600 mg is a standard effective dose: no human dose-response data exists to support this.
- Claim about "synergistic" effects with another compound: the transcript cuts off before naming it, making this unverifiable.
- Recovery benefits: no human evidence cited or available.
What should you actually know?
If your testosterone is genuinely low, a supplement with only rat-study backing is not the clinical answer. Hypogonadism is a diagnosable condition with established treatments, and self-treating based on a TikTok product link carries real risks, including delay of actual diagnosis and exposure to compounds with unknown human safety profiles.
The FDA does not regulate supplements for efficacy. A product can be sold legally while having no credible evidence it does what the label claims. Fadogia agrestis products on the market vary widely in purity and actual alkaloid content, which makes the creator's confident dosing statements even less meaningful.
If you're concerned about testosterone, get a blood panel. A clinician can tell you whether your levels are actually low, whether the drop is symptomatic, and what evidence-based options exist. That conversation is more useful than any supplement stack, and it doesn't require thanking anyone later.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Shad Asiama · TikTok creator
6.3K views on this video
This doctor exposed the “natty trt” supplement #fadogiaagrestis #fitness
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about zero published human rcts have tested whether fadogia agrestis raises?
Zero published human RCTs have tested whether fadogia agrestis raises testosterone in men at any dose.
What does the video say about the primary cited study (yakubu et al., 2005) used rats,?
The primary cited study (Yakubu et al., 2005) used rats, not humans, and rat testosterone physiology does not reliably predict human outcomes.
What does the video say about a follow-up animal study (yakubu et al., 2008, journal of?
A follow-up animal study (Yakubu et al., 2008, Journal of Ethnopharmacology) identified potential testicular toxicity signals at higher doses, contradicting the safety framing in the video.
What does the video say about a 300-700 ng/dl testosterone increase from an?
A 300-700 ng/dL testosterone increase from an oral supplement would be clinically extraordinary and has no supporting human evidence.
What does the video say about low testosterone?
Low testosterone is a diagnosable condition. Serum testosterone and LH testing through a licensed provider is the appropriate first step, not a supplement purchase.
What does the video say about the fda does not evaluate supplements for efficacy before they?
The FDA does not evaluate supplements for efficacy before they reach market, meaning product claims are not independently verified.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Shad Asiama, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.